Selling and marketing expense was $1.4 million for the second quarter of 2025 compared with $1 million the second quarter of 2024. The increase was due to higher trade show expenses, higher costs related to clinical studies, and higher payroll costs due to an increase in headcount.

Aug 7, 2025 / CFO / receipt, needs a key / Javier Rampolla, CFO | earnings call 2025-08-07 | transcript 1246344d-dcda-4f4e-831d-31080fb7af80 | chars 10833-11115 | segment 11

Selling and marketing expense was $3.6 million for the first nine months of 2024, down from $5 million a year ago. The difference was primarily attributable to a decline in marketing agency expense, travel expense, and lower headcount.

Nov 14, 2024 / CFO / receipt, needs a key / Javier Rampolla, CFO | earnings call 2024-11-14 | transcript b1ceb232-fd39-4664-9023-161e24637c70 | chars 11613-11848 | segment 11

The lead on marketing expense for the fourth quarter of 2023 was 0.6 million compared with 1.6 million for the fourth quarter of 2022. The decrease was primarily attributable to lower compensation expense partially upset by higher trade show costs.

Feb 8, 2024 / CFO / receipt, needs a key / Javier Rampolla, CFO | earnings call 2024-02-08 | transcript e29befa4-c8e9-47a1-be88-53bc80414dab | chars 9661-9909 | segment 9

Selling and marketing expense for the first quarter of 2023 was $2.1 million compared with $1.2 million for the first quarter of 2022. The increase was attributable to higher trade show and advertising expense. Note that we have increased our participation in regional trade shows that are attended by our target customers These are considerably less expensive than large national shows and are an efficient way of using our cash.

May 3, 2023 / CFO / receipt, needs a key / Javier Rampolla, CFO | earnings call 2023-05-03 | transcript 0fdd84d5-4937-4ef6-bb5f-0aa8db6ca166 | chars 9848-10278 | segment 9

Selling and marketing expenses was $3.5 million for the first nine months of 2021, compared with $4 million for the first nine months of 2020. The decrease was primarily attributable to lower threshold expense due to cancellations related to COVID-19, reduced marketing activities including travel, and lower salary and benefit expenses due to reduced headcounts, partially offset by an increase in commission expense.

Nov 4, 2021 / CFO / receipt, needs a key / Javier Rampolla, CFO | earnings call 2021-11-04 | transcript f9ec8504-7b3f-4780-b655-b6f7bf7c1374 | chars 15105-15523 | segment 15